Evidence map›Paper›PMID 35466028›Full record

ReviewTrends in cell biology2022

Moonlighting translation factors: multifunctionality drives diverse gene regulation.

Dorian Farache, Sadie P Antine, Amy S Y Lee

Open access · greenAbstract readReview
In one paragraph

Review in Trends in cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Human Tissues Exhibit Diverse Composition of Translation Machinery.International journal of molecular sciences · 2023
    Article
  8. Plant terminators: the unsung heroes of gene expression.Journal of experimental botany · 2023
    Review
  9. Article
  10. Increasing Complexity of Ribosomes and Their Biogenesis.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dorian FaracheDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Sadie P AntineDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amy S Y LeeDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: amysy_lee@dfci.harvard.edu.
Harvard University · US

Funding

Notice of Special Interest - R35 (Undergraduate Summer Funding)R35GM142527 · NIGMS · DANA-FARBER CANCER INST · PI LEE, AMY SI-YING · 2021 to 2025
$2.2M
NIGMS NIH HHS R35 GM142527
6 · The paper itself

Abstract

Translation factors have traditionally been viewed as proteins that drive ribosome function and ensure accurate mRNA translation. Recent discoveries have highlighted that these factors can also moonlight in gene regulation, but through functions distinct from their canonical roles in protein synthesis. Notably, the additional functions that translation factors encode are diverse, ranging from transcriptional control and extracellular signaling to RNA binding, and are highly regulated in response to external cues and the intrinsic cellular state. Thus, this multifunctionality of translation factors provides an additional mechanism for exquisite control of gene expression.

Indexed as

Protein BiosynthesisRibosomesGene Expression RegulationHumansProteinsProteinseIFsgene regulationribosometranslation

Identifiers

PMID35466028
PMCPMC9378348
OpenAlexW4224271035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.